Podcasts about risk factors

In today's episode, I sit down with entrepreneur Charles Yeomans, CEO of Atombeam Technologies, to talk about a real data bottleneck hiding in plain sight. We break down why most machine generated data never makes it through the network, how Atombeam's Nerpak software moves far more information without new hardware, and why that matters for defense, mobility, storage, and edge computing. Charles explains how shrinking data changes security and situational awareness, what this means for AI operating outside massive data centers, and why crowdfunding became the right path for backing a seasoned founder building infrastructure level technology. This Reg A offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please review the Offering Circular and Risk Factors before investing. Link to invest: https://www.startengine.com/offering/atombeam

Reflections on the Peter Attia/Epstein scandal; How to lower lp(a)—does diet help? What are bio-active peptides? Could they stave off kidney disease? Scientists just tested the fittest 81-year-old in the world—here's what they found; Media erroneously report that intermittent fasting is not effective for weight loss; Sugary drinks may stoke anxiety in teens; Omega-3s support kids' reading fluency and spelling scores; Surprising study shows saturated fats not harmful to kidneys.

On episode #100 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 1/29/26 – 2/11/26. Host: Daniel Griffin and Sarah Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis (PNAS) Dengue Suppression by Male Wolbachia-Infected Mosquitoes (NEJM) Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review (Vaccine) Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study (OFID) Adenoviral Inciting Antigen and Somatic Hypermutation in VITT (NEJM) Bacterial Extraintestinal Invasive Escherichia coli Infections in the US (JAMA Network OPEN) Clinical Manifestations, Long-Term Trends, and Risk Factors for Treatment Failure in Native Vertebral Osteomyelitis: A 26-Year Mayo Clinic Experience (CID) US Emergency Department Visits forAntibiotic Adverse Drug Events in Children, 2019-2023 (Journal of the Pediatric Infectious Diseases Society) Fungal The Last of US Season 2 (YouTube) Albumin orchestrates a natural host defence mechanism against mucormycosis (Nature) Pseudo-Outbreak of Purpureocillium lilacinum Skin Infections at a Dermatology Clinic — Washington, 2024 (CDC: MMWR) Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023 (Emerging Infectious Diseases) Parasitic Trichinellosis: A zoonosis that still requires vigilance (PLoS Neglected Tropical Diseases) Trichinellosis after Raw Bear Eyeball Consumption (AJTMH: American Journal of Tropical Medicine and Hygiene) Moving Scabies Under Video-Dermoscopy (AJTMH: American Journal of Tropical Medicine and Hygiene) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

In this episode of The Cardiac Recovery Room, moderator Dr. Daniel Engelman, Medical Director of the Cardiac Surgical Critical Care & Inpatient Services at Baystate Health, Professor of Surgery at the University of Massachusetts Chan Medical School—Baystate, and President of the ERAS Cardiac Society; and co-moderator Dr. Kevin Lobdell, Professor and Director of Regional Cardiovascular and Thoracic Quality, Education, and Research at Atrium Health spoke with Dr. Rawn Salenger, Chief of Cardiac Surgery at the University of Maryland St. Joseph Medical Center and Dr. Serdar Gunaydin, Head of Department at the University of Health Sciences in Turkey, about patient blood management.   Chapters  00:00 Intro  01:14 Transfusion as a Risk Factor  07:08 Hemoglobin Drugs  08:24 Pillars of Blood Management  09:56 Anesthesia  12:30 Transfusion Triggers  17:33 O2 Delivery, Hemoglobin Number  22:20 Non-Transfusion Patients  23:22 Anemic Level Bottom Number  25:06 Bleeding Checklist  29:41 Anemia Tolerance  They discussed independent risk factors for blood transfusion, the role of hemoglobin as a predictor for blood transfusion, and considerations related to anemic patients and hemoglobin levels. Additionally, they explored the key pillars of blood management, treating preoperative anemia, and anesthesia. They examined transfusion triggers, oxygen delivery, and the care of non-transfusion patients. Finally, they emphasized the importance of a bleeding checklist and anemia tolerance.   The Cardiac Recovery Room is the place to hear the conversations colleagues are having after the meetings. Each month, a new episode will be released featuring a leadership panel from the ERAS Cardiac Society.  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Send a textIn this episode of the PT Snacks Podcast, host Kasey delves into vertebra basilar insufficiency (VBI), a condition affecting the posterior cerebral circulation. Aimed at physical therapists and PT students, the episode explains the anatomy behind VBI, its symptoms, risk factors, and how to screen for it effectively. Kasey highlights the importance of understanding VBI's implications, potential triggers, and the role of physical therapists in identifying and managing this condition. The episode also touches on appropriate referral procedures and the limitations of traditional VBI tests. Listen in to enhance your knowledge and clinical skills regarding this critical topic.00:00 Introduction to PT Snacks Podcast00:15 Understanding Vertebra Basilar Insufficiency01:33 Anatomy Review: Blood Supply to the Brain05:17 Risk Factors for Vertebra Basilar Insufficiency06:16 Identifying VBI in the Clinic09:16 Diagnostic Tests and Safe Practices11:33 Referral Guidelines and Patient Communication13:52 Conclusion and Additional ResourcesSupport the showNeed CEUs? Unlock unlimited online courses, live webinars, and certification-prep programs with MedBridge. You'll get: Thousands of accredited, evidence-based courses across multiple specialties (PT, OT, AT, SLP) that count for state-license CEUs. Access anytime, from your office, phone, or home—perfect for busy clinicians. One annual subscription, no per-course fee. Special offers: Use code PTSNACKSPODCAST at checkout and save over $100. Students use code PTSNACKSPODCASTSTUDENT for a discounted annual plan. Studying for the NPTE? Check out PT Final Exam — they've helped thousands of students pass with confidence. Use code PTSnacks at checkout for a discount. Stay Connected! Follow so you never miss an episode. Send your questions via email to ptsnackspodcast@gmail.com Join the email list ...

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Every week brings two ways to grow: Tuesdays dive into the physical next steps with real-life guidance for seniors and families, and Fridays uplift the heart with spiritual and emotional next steps—encouragement, faith, and hope for the journey ahead. To learn more about Next Steps 4 Seniors, contact us at 248-651-5010 or visit us online at www.nextsteps4seniors.com Find us on YouTube at https://www.youtube.com/@nextsteps4seniorsLearn more : https://omny.fm/shows/next-steps-4-seniors-with-wendy-jonesSee omnystudio.com/listener for privacy information.

Focus Issue on Improving prevention - Traditional & Non-traditional Risk Factors

In this episode of the Holistic Dentistry Show, Dr. Sanda Moldovan interviews Angela Pifer, a functional medicine nutritionist, about Small Intestinal Bacterial Overgrowth (SIBO). They discuss the symptoms, causes, and distinctions between SIBO and Irritable Bowel Syndrome (IBS). Angela shares insights on the triggers for SIBO, including food poisoning and stress, and emphasizes the importance of digestion and gut health. The conversation also covers treatment approaches, including the role of antibiotics and the need for a holistic recovery of gut health. In this conversation, Dr. Sanda Moldovan and Angela Pifer delve into the complexities of SIBO (Small Intestinal Bacterial Overgrowth) and its treatment, emphasizing the importance of understanding underlying causes rather than relying solely on antibiotics. They discuss the role of the vagus nerve, the impact of mold on health, and the significance of a holistic approach to gut health. Angela shares insights from her upcoming SIBO Summit, which aims to provide practical tools for improving gut health and overall well-being. Want to see more of The Holistic Dentistry Show? Watch our episodes on YouTube! Do you have a mouth- or body-related question for Dr. Sanda? Send her a message on Instagram! Remember, you're not healthy until your mouth is healthy. So take care of it in the most natural way.  Key Takeaways: (00:00) Introduction to SIBO and Its Symptoms (03:02) Understanding SIBO: Causes and Mechanisms (06:06) Distinguishing SIBO from IBS (09:01) Triggers and Risk Factors for SIBO (12:00) The Role of Stress and Digestion (14:54) Antibiotics and Treatment Approaches for SIBO (19:05) Understanding Post-Infectious IBS and Treatment Approaches (22:30) Concerns Over Antibiotic Use and Resistance (25:54) The Importance of Addressing Root Causes (27:52) The Impact of Mold on Health (30:22) Insights from the SIBO Summit (32:47) Practical Tools for Vagus Nerve Health Guest Info: @sibo.guru Connect With Us:  AskDrSanda | YouTube BeverlyHillsDentalHealth.com | Instagram  DrSandaMoldovan.com | Instagram  Orasana.com | Instagram

The high rates of failures and reoperations (up to 50%) after arthroscopic posterior Bankart repair (APBR) remain a concern.   In conclusion, in patients with recurrent posterior instability, the presence of posterior glenoid erosion was the main risk factor for failure after APBR. By contrast, a posterior bony Bankart lesion did not represent a contraindication to arthroscopic stabilization using suture anchor fixation.   Click here to read the article.

Dr. Fiorinda Muhaj discusses the risk factors for developing BCC, and how it is diagnosed.

FREE RESOURCE:  Try our Cyclical Nourishment Guide: https://rebeltribe.thrivecart.com/cyclical-living-nutrition/ In this heartfelt conversation, Dr. Beverly Huang shares her personal journey of being diagnosed with breast cancer, emphasizing the importance of advocacy, awareness, and understanding breast density.  She discusses the emotional challenges of her diagnosis, the significance of community support, and the need for women to take charge of their health by understanding their risk factors.  The conversation highlights the necessity of open communication with loved ones and the power of sharing knowledge to empower others. Dr. Huang's insights serve as a reminder of the importance of self-advocacy in healthcare and the impact of connection during difficult times. Tyrer- Cuzick Risk Assessment Calculator: HERE Ontario Breast Screening Program at 1-800-668-9304   Takeaways Beverly emphasizes the importance of sharing her story to empower other women. Advocacy for one's health is crucial, especially in navigating medical systems. Understanding breast density is vital for assessing risk factors for breast cancer. Women should not hesitate to self-refer for mammograms when necessary. Emotional processing of a cancer diagnosis can include anger and acceptance. Community support plays a significant role in coping with health challenges. Open conversations with loved ones about health issues can alleviate fears. Women often feel the need to buffer others' emotions during their own health crises. Self-advocacy in healthcare is essential for receiving appropriate care. The absence of connection can lead to feelings of isolation during health struggles.   Chapters 00:00 Introduction and Personal Connection 02:27 Beverly's Diagnosis and Its Impact 04:05 Advocacy for Women's Health 06:27 The Importance of Mammograms 09:21 Understanding Breast Density and Risk Factors 11:51 Navigating the Healthcare System 14:15 The Tyroacusic Breast Cancer Risk Assessment 16:51 Personal Stories and Realizations 19:37 Processing the Diagnosis 22:22 Emotional Responses and Support 26:34 Understanding Grief and Anger 28:07 Finding Peace in the Journey 30:04 The Gift of Time and Preparation 31:27 Choosing Love Over Fear 34:41 The Power of Connection 38:48 Navigating Conversations Around Illness 51:05 Navigating Personal Pain and Collective Suffering 54:05 Communicating Health Challenges with Loved Ones 56:59 The Importance of Humor and Lightness in Serious Times 01:01:28 Understanding Breast Density and Health Advocacy 01:07:34 The Need for Informed Healthcare Decisions 01:11:56 Empowerment Through Knowledge and Community Support   Stay Wild. Connect with Dr. Beverly Huang on INSTAGRAM Connect with Dr. Michelle Peris on INSTAGRAM FREE RESOURCE:  Click the link and see if the SHED METABOLIC RESET PROGRAM is a good fit for you!  This episode is brought to you by: www.MichellePeris.com Ready to reclaim your Wild? JOIN THE WAITLIST Learn more about The Poppy Clinic: www.poppyclinic.com Is Naturopathic Medicine for you: LEARN MORE HERE Take our HORMONE QUIZ Are you a clinician looking for more impact? START HERE

In this episode of Rounding@IOWA, Dr. Gerry Clancy sits down with breast cancer experts Dr. Katherine Huber‑Keener and Dr. Nicole Fleege for a discussion of modifiable and non‑modifiable risk factors, modern screening tools, and practical strategies clinicians can use to guide prevention and early detection. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=82146  Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guests: Nicole Fleege, MD Clinical Assistant Professor of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation University of Iowa Carver College of Medicine Kathryn Huber-Keener, MD PhD Clinical Associate Professor of Obstetrics and Gynecology - General Obstetrics and Gynecology University of Iowa Carver College of Medicine Financial Disclosures:  Dr. Gerard Clancy, his guests, and Rounding@IOWA planning committee members have disclosed no relevant financial relationships. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.75 ANCC contact hour. Pharmacist and Pharmacy Tech: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 0.75 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. JA0000310-0000-26-035-H99 Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)      

Hacking The Healthcare System: The Rise Of Subscription-Based DoctorsShould primary care be subscription-based? As the shortage of primary care physicians continues to worsen, many patients are struggling to secure timely appointments within the traditional healthcare system. This week, our expert explores the rise of alternative models that offer quicker access and more personalized attention through membership-based feesGuest: Dr. Jane Zhu, primary care physician, associate professor of medicine, Oregon Health and Science UniversityHost: Elizabeth WestfieldProducer: Kristen Farrah.   The Life-Threatening Link Between Menopause And Heart HealthMenopause is a time of major change in every woman's life, but while many focus on common symptoms like hot flashes, there's a lesser-known threat to long-term heart health. Dr. Priya Freaney reveals the critical importance of recognizing these risks and taking action to reduce the threat of heart disease and heart failure after menopause.Guests: Dr. Priya Freaney, cardiologist, assistant professor of medicine, Northwestern UniversityHost: Greg JohnsonProducers: Kristen Farrah Medical Notes: The New Community Flu Shot, A Better Treatment For Schizophrenia, And How Vitamins Can Protect Male FertilityA breakthrough in mental health treatment is offering new hope for those living with Schizophrenia. Scientists may have found the breakthrough for a flu shot that protects the community. Are vitamins the secret to male fertility? The thrill of the game may be fueling more than just team spirit. Host: Maayan Voss de BettancourtProducer: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week, join authors Shaan Khurshid and Julian S. Haimovich as they discuss their article "Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial." For the episode transcript, visit:  https://www.ahajournals.org/do/10.1161/podcast.20260209.180892

Welcome to Season 2 of the Orthobullets Podcast. Today's show is Podiums, where we feature expert speakers from live medical events. Today's episode will feature ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Jose Rodriguez is titled⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ "⁠⁠Iliopsoas Impingement After Direct Anterior Approach Total Hip Arthroplasty - Epidemiology, Risk Factors, Treatment.⁠⁠"⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube

The Life-Threatening Link Between Menopause And Heart HealthMenopause is a time of major change in every woman's life, but while many focus on common symptoms like hot flashes, there's a lesser-known threat to long-term heart health. Our expert reveals the critical importance of recognizing these risks and taking action to reduce the threat of heart disease and heart failure after menopause.Guests: Dr. Priya Freaney, cardiologist, assistant professor of medicine, Northwestern UniversityHost: Greg JohnsonProducers: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. David Jockers explores the hidden dangers of cholesterol medications, revealing how statins can cause more harm than good. You'll learn how these common drugs may increase your risk of type 2 diabetes, muscle loss, and even dementia. Dr. Jockers discusses the vital role cholesterol plays in your body, particularly for brain health and hormone production. He explains why lowering cholesterol may not be the solution, and how focusing on inflammation can be far more beneficial for your heart health. The episode also covers practical alternatives to statins, like a blood sugar-stabilizing diet, intermittent fasting, and the importance of exercise. Dr. Jockers offers actionable insights to improve your overall health without relying on medications. In This Episode:  00:00 Introduction to Statin Side Effects 02:10 Hidden Dangers of Statins 03:31 How Statins Work and Their Risks 06:51 Common Side Effects and Risk Factors 08:39 Alternatives to Statins 09:48 Diet and Lifestyle Recommendations 17:13 Conclusion and Final Thoughts   Optimize your health with Tro Scripts, offering the latest in fast-acting health optimization. Their unique delivery method, the buccal troche, infuses ingredients directly into the cheek for quicker absorption and higher bioavailability than traditional supplements. From Just Blue for cellular health to Tro Immune for immune support, their products are formulated by a team of physicians and crafted in the U.S. Visit TroScripts.com/DrJockers and enter code DrJockers for 10% off your first order.  This episode is brought to you by ARMRA Colostrum. ARMRA is nature's first whole food, packed with over 400 bioactive nutrients that strengthen your gut health, immune system, and overall vitality. In a world full of modern stressors and toxins, ARMRA helps bolster your health from within. It's a powerful way to support your immune function, improve performance, and maintain optimal health. Visit armra.com/drjockers and use the code DRJOCKERS to get 30% off your first subscription order.   "Statins may block essential energy production in your cells, contributing to fatigue and memory loss."  ~ Dr. Jockers     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio     Resources: Visit TroScripts.com/DrJockers and enter code DrJockers for 10% off your first order. Visit armra.com/drjockers and use the code DRJOCKERS to get 30% off your first subscription order. Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https:/www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/   If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

Asymmetries are normal — but not all asymmetries are created equal. In this episode of the Movement Podcast, Gray Cook and Lee Burton break down the difference between anatomical, functional, and developmental asymmetry, and explain when asymmetry becomes a slippery slope that impacts performance, durability, and injury risk.They also discuss why the goal isn't “perfect symmetry,” but keeping asymmetries from getting worse, and how movement screening helps coaches and clinicians make smarter training decisions.In this episode:• The 3 types of asymmetry: anatomical, functional, developmental• When asymmetry becomes a risk factor (and when it's just sport-specific)• Why “don't let it get worse” is the real goal• Key impairment asymmetries to watch: ankle dorsiflexion + grip strength• Why dynamic balance + functional patterns matter more than isolated measures• Practical ways to “scrub the corners” and restore awarenessMore from the Movement Podcast:  https://www.movementpod.com/Functional Movement Systems YouTube Facebook Instagram X (Twitter) Subscribe to the FMS Newsletter

The evidence is growing that suggest that microplastics, or more specifically smaller nanoplastics, are triggers for atherosclerotic disease with increased risk for heart attack, stroke, and death. While your doctor wastes your time and money obsessing about cholesterol and statin drugs that should have been discarded decades ago, you need to address the REAL factors that cause heart disease. Add nanoplastics to that list. Thankfully, you can begin to make an impact on your ingestion of plastic particles but may need to re-examine many long-accepted habits.Support the showYouTube channel: https://www.youtube.com/@WilliamDavisMD Blog: WilliamDavisMD.com Membership website for two-way Zoom group meetings: InnerCircle.DrDavisInfiniteHealth.com Books: Super Gut: The 4-Week Plan to Reprogram Your Microbiome, Restore Health, and Lose Weight Wheat Belly: Lose the Wheat, Lose the Weight and Find Your Path Back to Health; revised & expanded ed

In this episode of One in Ten, host Teresa Huizar speaks with Dr. Robin Ortiz, an assistant professor in the Department of Pediatrics at NYU Grossman School of Medicine, about neglect recurrence in child abuse cases. Dr. Ortiz discusses the factors contributing to neglect recurrence, including adverse childhood experiences (ACEs), environmental influences, and societal factors. They explore the gaps in the literature, the complexities of defining neglect, and the need for tailored interventions. Findings from Dr. Ortiz's recent research indicate that various risk factors exist at the child, family, community, and policy levels, and they emphasize the importance of societal investment in mental health, substance abuse treatment, domestic violence intervention, and financial stability to prevent neglect. The episode highlights the need for a comprehensive approach to support families and break the cycle of neglect.  Time Stamps  Time Topic 00:00 Introduction and Guest Introduction 00:13 Understanding Neglect Recurrence 01:11 Guest's Background and Research Focus 03:11 Literature Review on Child Maltreatment Recurrence 05:33 Defining Neglect and Its Challenges 10:08 Study Hypotheses and Findings 18:26 Risk Factors for Neglect Recurrence 25:07 Impact of Services on Neglect Recurrence 38:24 Policy Implications and Societal Responsibility 41:03 Conclusion and Takeaways ResourcesChild, Family and Societal Factors Related to Neglect Recurrence After CPS Investigation - Robin Ortiz, Vincent J. Palusci, 2025Support the showDid you like this episode? Please leave us a review on Apple Podcasts.

Dr. Kevin Klingele, fellowship director and chief of pediatric orthopaedics at Nationwide Children's, joins the show to discuss his recent research on ligamentum teres reconstruction. As an interlude, Dr. Dan Perry also returns to the podcast to provide an update on the SCIENCE Trial, comparing surgery and non-surgical care for children with displaced medial epicondyle fractures. Your hosts are Carter Clement from Manning Family Children's in New Orleans, Will Morris from TSRH, Tyler McDonald from USA, Stephanie Logterman from the Arnold Palmer Hospital for Children, and Josh Holt from Iowa. Music by A.A. Aalto.   References:   “Open Reduction With Ligamentum Teres Reconstruction—Preliminary Results of a Novel Technique for the Management of Pediatric Developmental Dysplasia of Hip.” Englert et al. JPO 2025.   “Early-Onset Perthes Disease in Patients Under 4 Years of Age: Natural Disease History, Radiographic Findings, and Prognostic Factors.” Garcia-Fernandez et al. JPO 2025.   “More Amputations and Open Fractures: Pediatric Utility Task Vehicle (UTV) Injuries Are More Severe Than All-terrain Vehicle (ATV) Injuries.” Jaggers et al. JPO 2026.   “Long-Term Outcome of Idiopathic Increased Femoral Anteversion in 58 Untreated Individuals at a Mean Age of 46.2 Years.” Gronseth et al. JPO 2026.   “Improving Postoperative Pain Management in Pediatric Supracondylar Humerus Fractures With Local Anesthesia.” Gunda et al. JPO 2026.   “Risk Factors for Nonunion After Femoral Rotational Osteotomy for Idiopathic Anteversion and Retroversion in Adolescents.” Roper et al. JPO 2026.   “Off With the Head: Decreasing Complications With Headless Compression Screws for Tibial Tubercle Fracture Fixation.” Menapace et al. JPO 2026.

In this episode of Liver Lineup: Updates and Unfiltered Insights, Nancy Reau, MD, and Kimberly Brown, MD, turn their attention to metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH), conditions that now dominate hepatology clinics but continue to pose major diagnostic and therapeutic challenges. As new drugs enter the clinic and others advance through the pipeline, the hosts explore what meaningful progress looks like in a disease space defined by heterogeneity, comorbidities, and ongoing uncertainty around long-term outcomes.Key episode timestamps:0:00:00 – Intro + global MASLD burden and mortality; who progresses to severe liver disease.0:03:00 – Very low disease awareness; advanced MASLD often missed.0:06:32 – Weak FIB‑4–based referral patterns; need automated pathways.0:10:54 – Alcohol underreporting; role of PEth in honest discussions.0:15:18 – “Modest” alcohol still harmful in MASLD; no truly safe level.0:19:40 – Semaglutide/GLP‑1 benefits on liver outcomes beyond weight loss.0:23:22 – FGF‑21 agents improving portal hypertension in advanced disease.0:24:03 – Carvedilol less effective for variceal bleed prevention in MASLD.0:28:45 – Closing remarks; call for better disease control and systems of care.

On episode #99 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 1/15/26 - 1/28/26. Host: Daniel Griffin and Sarah Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Symptomatic and asymptomatic norovirus infections in early life; The PREVAIL Cohort, 2017-2020 (CID) Bacterial Xenodiagnosis to search for Borrelia burgdorferi after antibiotic treatment of Lyme disease: a prospective cohort study (CID) Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia (CID) Methodology Misrepresented: Correcting the Record on the ATS Community-acquired Pneumonia Guideline Process (CID) Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Surve (Journal of the Pediatric Infectious Diseases Society) Antibiotic Therapy for Uncomplicated AcuteAppendicitis (JAMA) Fungal The Last of US Season 2 (YouTube) Persistence of Symptoms among Commercially Insured Patients with Coccidioidomycosis, United States, 2017–2023 (CDC: Emerging Infectious Diseases) Ophthalmologic evaluation and clinical outcome in candidemia: a seven-year retrospective multicenter cohort study (OFID) Parasitic Postinfectious Syndromes and Long-Term Sequelae after Giardia Infections (CDC: Emergining Infectious Diseases) Priced Out of Treatment: The Exorbitant Cost of Antiparasitic Drugs in the United States (OFID) Miscellaneous All About the AAP Recommended Immunization Schedule (healthychildren.org) Recommended Childhood and Adolescent Immunization Schedule: United States, 2026: Policy Statement (American Academy of Pediatrics: Pediatrics) Feeling the Vibes: An Investigation into Resident Antibiotic Prescribing Practices (OFID) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management. Through real-world case discussions, Dr Sattar demonstrates practical decision-making for patients across the spectrum - from pre-diabetes to established CAD with Type 2 diabetes. He addresses the tension between robust evidence and cost barriers that limit widespread implementation, while acknowledging unprecedented patient demand driven by genuine quality of life improvements. The conversation concludes with insights on obesogenic environments and the hope that increased competition will ultimately democratize access to these transformative therapies. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

Dr. Tesha Monteith and Dr. Michael Eller discuss the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Show citation: Eller MT, Schwarzová K, Gufler L, et al. CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review. Neurology. 2025;105(2):e213852. doi:10.1212/WNL.0000000000213852  Show transcript:  Dr. Tesha Monteith: Hi, this is Tesha Monteith with the Neurology Minute. I've just been speaking with Michael Eller from the Department of Neurology Medical University of Innsbruck, Austria on the neurology podcast on his paper, CGRP Targeted Migraine Therapies in Patients with Vascular Risk Factors or Stroke: A Review. Hi, Michael. Dr. Michael Eller: Hello. Dr. Tesha Monteith: Why don't you summarize your general approach to use of CGRP targeted therapies in patients that might be at risk for vascular events when considering safety? Dr. Michael Eller: Yeah. About acute vascular events, we should stop CGLP targeted drugs immediately. When we come to post-stroke, we should reassess the necessity of these targeted treatments after recovery. We suggest a minimum of three months pause after ischemic stroke to allow early recovery and remodeling, and then restart only after individualized benefit risk review. In high-risk primary prevention, so no stroke yet, but elevated risk, if the patients are 65 years or older with established cardiovascular disease, we should prefer traditional preventives. And if CGLP targeted therapy is essential, we should consider Gepants cautiously due to their shorter half lives. We should avoid CGLP targeted treatments in small vessel disease, distal stenosis, Raynaud's phenomenon, and uncontrolled hypertension. For acute migraine treatment, we can consider gepants or ditans as alternatives to triptans and NSAIDs in relevant stroke risk or post-stroke patients, individualized to comorbidities. Dr. Tesha Monteith: Great. And we should say that the label updates include hypertension and Raynaud's phenomenon as potential vascular complications. Otherwise, these are more theoretical risks based on what we know about CGRP. Dr. Michael Eller: Yes, I totally agree because large studies did not show any elevated cardiovascular risk signals. And for post-marketing databases, we did not see any elevated cardiovascular risk so far. However, in pre-clinical settings, studies showed large infarct size in pretreated mice. Dr. Tesha Monteith: Great. Well, thank you again for doing this work. It was a phenomenal read and congratulations. Dr. Michael Eller: Thank you. Dr. Tesha Monteith: This is Tesha Monteith. Thank you for listening to the Neurology Minute.

Preeclampsia is one of those pregnancy conditions that gets mentioned often, explained poorly, and frequently dismissed until it suddenly isn't. In this episode, HeHe sits down with Dr. Dallas Reed to pull back the curtain on what preeclampsia actually is, how it shows up, and what expectant parents deserve to understand long before things feel urgent. Together, they break down the basics in a way that's clear and human, including how common preeclampsia really is, what symptoms to take seriously, and how to make sense of blood pressure readings and pregnancy-related hypertension diagnoses. Dr. Reed explains the differences between severe and non-severe preeclampsia, what monitoring can look like before and after 37 weeks, and why postpartum preeclampsia deserves more attention than it often gets. The conversation also explores prevention and management, including lifestyle considerations, aspirin use, and how care plans may differ depending on risk level, gestational age, and whether someone is being monitored inpatient or outpatient. A major focus of the episode is the future of personalized maternal care, including a deep dive into the Encompass test. This new RNA-based blood test, available between 18 and 22 weeks, helps identify pregnancies at higher risk for preeclampsia and pairs that insight with an evidence-based action plan and virtual support. Dr. Reed shares how this type of testing may change the way providers and families approach monitoring, communication, and early intervention, including potential benefits for out-of-hospital birth settings. This episode is grounded, evidence-based, and empowering, offering expectant parents tools, language, and understanding so they can participate confidently in their care rather than feeling blindsided by it.   TIMESTAMPS 00:00 Introduction to Preeclampsia 00:56 Welcome to The Birth Lounge Podcast 01:39 Features of The Birth Lounge App 03:00 Pregnancy and Postpartum Articles 04:54 Introduction to Today's Episode 07:47 Discussion with Dr. Dallas Reed 08:35 Understanding Preeclampsia 10:46 Symptoms and Diagnosis 18:56 Managing Blood Pressure During Pregnancy 22:37 Risk Factors and Prevention 31:59 Strategies to Prevent Preeclampsia 32:29 Healthy Lifestyle Recommendations 33:37 Monitoring and Follow-Up 35:05 Risks and Complications of Preeclampsia 37:05 Postpartum Preeclampsia 39:20 Managing Preeclampsia Before 37 Weeks 41:20 Inpatient Care and Medications 46:22 Understanding the Encompass Test 53:06 Benefits of the Encompass Test for Home Births 58:19 Final Thoughts and Resources   Guest Bio: Dr. Dallas Reed, practicing OBGYN, medical geneticist and advisor to Mirvie, a company delivering data-driven solutions for predictive and preventive care in pregnancy. Mirvie recently launched Encompass, which is the first RNA-based blood test to predict preeclampsia risk, combined with an evidence-based preventive action plan and virtual assistant to guide individualized support and care.    SOCIAL MEDIA: Connect with HeHe on Instagram  Connect with Mirvie on IG    BIRTH EDUCATION: Join The Birth Lounge for judgment-free, evidence-based childbirth education that shows you exactly how to navigate hospital policies, avoid unnecessary interventions, and have a trauma-free labor experience, all while feeling wildly supported every step of the way Want prep delivered straight to your phone? Download The Birth Lounge App for bite-sized birth and postpartum tools you can use anytime, anywhere. And if you haven't grabbed it yet… Snag my free Pitocin Guide to understand the risks, benefits, and red flags your provider may not be telling you about, so you can make informed, powerful decisions in labor.  

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the Januray 2026 Emergency Medicine Practice article, Emergency Department Diagnosis and Management of Patients With SyphilisSyphilis cases have surged 42% in the US, making it critical for emergency physicians to recognize and treat this "great masquerader." In this episode, hosts Sam Ashoo and Dr. T.R. Eckler break down the January 2026 Emergency Medicine Practice article on syphilis diagnosis and management. They cover the rising prevalence in high-risk populations, the four clinical stages (primary, secondary, latent, and tertiary), special presentations like neurosyphilis and congenital syphilis, and practical diagnostic approaches. With a national penicillin shortage, they discuss alternative treatment options including doxycycline and post-exposure prophylaxis. The conversation also addresses the dark history of the Tuskegee Study and its lasting impact on medical ethics. Whether you're seeing more cases in your ED or want to sharpen your diagnostic skills, this episode provides actionable insights for frontline providers.Timestamps[0:00] Opening/Introduction[0:11] Host Welcome & Resources[0:50] Episode Introduction[1:30] Epidemiology & Rising Cases[4:30] Risk Factors & Screening[6:30] Pathophysiology & Transmission[9:30] Primary Syphilis[12:30] Secondary Syphilis[15:30] Tertiary & Latent Syphilis[18:30] Neurosyphilis[22:30] Congenital Syphilis[25:30] Ocular & Otic Syphilis[28:30] Differential Diagnosis & Pre-hospital Care[31:30] History & Physical Examination[34:30] Diagnostic Testing Overview[38:30] Testing Details & Titers[41:30] Treatment: Penicillin & Alternatives[43:30] ClosingSubscribers, take the CME test here.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Psychogenic nonepileptic seizures (PNES) are common, often misunderstood, and increasingly encountered in pediatric emergency care. These events closely resemble epileptic seizures but arise from abnormal brain network functioning rather than epileptiform activity. In this episode of PEM Currents, we review the epidemiology, pathophysiology, and clinical features of PNES in children and adolescents, with a practical focus on Emergency Department recognition, diagnostic strategy, and management. Particular emphasis is placed on seizure semiology, avoiding iatrogenic harm, communicating the diagnosis compassionately, and understanding how early identification and referral to cognitive behavioral therapy can dramatically improve long-term outcomes. Learning Objectives Identify key epidemiologic trends, risk factors, and semiological features that help differentiate psychogenic nonepileptic seizures from epileptic seizures in pediatric patients presenting to the Emergency Department. Apply an evidence-based Emergency Department approach to the evaluation and initial management of suspected PNES, including strategies to avoid unnecessary escalation of care and medication exposure. Demonstrate effective, patient- and family-centered communication techniques for explaining the diagnosis of PNES and facilitating timely referral to appropriate outpatient therapy. References Sawchuk T, Buchhalter J, Senft B. Psychogenic Nonepileptic Seizures in Children-Prospective Validation of a Clinical Care Pathway & Risk Factors for Treatment Outcome. Epilepsy & Behavior. 2020;105:106971. (PMID: 32126506) Fredwall M, Terry D, Enciso L, et al. Outcomes of Children and Adolescents 1 Year After Being Seen in a Multidisciplinary Psychogenic Nonepileptic Seizures Clinic. Epilepsia. 2021;62(10):2528-2538. (PMID: 34339046) Sawchuk T, Buchhalter J. Psychogenic Nonepileptic Seizures in Children - Psychological Presentation, Treatment, and Short-Term Outcomes. Epilepsy & Behavior. 2015;52(Pt A):49-56. (PMID: 26409129) Labudda K, Frauenheim M, Miller I, et al. Outcome of CBT-based Multimodal Psychotherapy in Patients With Psychogenic Nonepileptic Seizures: A Prospective Naturalistic Study. Epilepsy & Behavior. 2020;106:107029. (PMID: 32213454) Transcript This transcript was generated using Descript automated transcription software and has been reviewed and edited for accuracy by the episode's author. Edits were limited to correcting names, titles, medical terminology, and transcription errors. The content reflects the original spoken audio and was not substantively altered. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski, and today we are talking about psychogenic non-epileptic seizures, or PNES. Now, this is a diagnosis that often creates a lot of uncertainty in the Emergency Department. These episodes can be very scary for families and caregivers and schools. And if we mishandle the diagnosis, it can lead to unnecessary testing, medication exposure, ICU admissions, and long-term harm. This episode's gonna focus on how to recognize PNES in pediatric patients, how we make the diagnosis, what the evidence says about management and outcomes, and how what we do and what we say in the Emergency Department directly affects patients, families, and prognosis. Psychogenic non-epileptic seizures are paroxysmal events that resemble epileptic seizures but occur without epileptiform EEG activity. They're now best understood as a subtype of functional neurological symptom disorder, specifically functional or dissociative seizures. Historically, these events were commonly referred to as pseudo-seizures, and that term still comes up frequently in the ED, in documentation, and sometimes from families themselves. The problem is that pseudo implies false, fake, or voluntary, and that implication is incorrect and harmful. These episodes are real, involuntary, and distressing, even though they're not epileptic. Preferred terminology includes psychogenic non-epileptic seizures, or PNES, functional seizures, or dissociative seizures. And PNES is not a diagnosis of exclusion, and it does not require identification of psychological trauma or psychiatric disease. The diagnosis is based on positive clinical features, ideally supported by video-EEG, and management begins with clear, compassionate communication. The overall incidence of PNES shows a clear increase over time, particularly from the late 1990s through the mid-2010s. This probably reflects improved recognition and access to diagnostic services, though a true increase in occurrence can't be excluded. Comorbidity with epilepsy is really common and clinically important. Fourteen to forty-six percent of pediatric patients with PNES also have epilepsy, which frequently complicates diagnosis and contributes to diagnostic delay. Teenagers account for the highest proportion of patients with PNES, especially 15- to 19-year-olds. Surprisingly, kids under six are about one fourth of all cases, so it's not just teenagers. We often make the diagnosis of PNES in epilepsy monitoring units. So among children undergoing video-EEG, about 15 to 19 percent may ultimately be diagnosed with PNES. And paroxysmal non-epileptic events in tertiary epilepsy monitoring units account for about 15 percent of all monitored patients. Okay, but what is PNES? Well, it's best understood as a disorder of abnormal brain network functioning. It's not structural disease. The core mechanisms at play include altered attention and expectation, impaired integration of motor control and awareness, and dissociation during events. So the patients are not necessarily aware that this is happening. Psychological and psychosocial features are common but not required for diagnosis and may be less prevalent in pediatric populations as compared with adults. So PNES is a brain-based disorder. It's not conscious behavior, it's not malingering, and it's not under voluntary control. Children and adolescents with PNES have much higher rates of psychiatric comorbidities and psychosocial stressors compared to both healthy controls and children with epilepsy alone. Psychiatric disorders are present in about 40 percent of pediatric PNES patients, both before and after the diagnosis. Anxiety is seen in 58 percent, depression in 31 percent, and ADHD in 35 percent. Compared to kids with epilepsy, the risk of psychiatric disorders in PNES is nearly double. Compared to healthy controls, it is up to eight times higher. And there's a distinct somatopsychiatric profile that strongly predicts diagnosis of PNES. This includes multiple medical complaints, psychiatric symptoms, high anxiety sensitivity, and solitary emotional coping. This profile, if you've got all four of them, carries an odds ratio of 15 for PNES. Comorbid epilepsy occurs in 14 to 23 percent of pediatric PNES cases, and it's associated with intellectual disability and prolonged diagnostic delay. And finally, across all demographic strata, anxiety is the most consistent predictor of PNES. Making the diagnosis is really hard. It really depends on a careful history and detailed analysis of the events. There's no single feature that helps us make the diagnosis. So some of the features of the spells or events that have high specificity for PNES include long duration, so typically greater than three minutes, fluctuating or asynchronous limb movements, pelvic thrusting or side-to-side head movements, ictal eye closure, often with resisted eyelid opening, ictal crying or vocalization, recall of ictal events, and rare association with injury. Younger children often present with unresponsiveness. Adolescents more commonly demonstrate prominent motor symptoms. In pediatric cohorts, we most frequently see rhythmic motor activity in about 27 percent, and complex motor movements and dialeptic events in approximately 18 percent each. Features that argue against PNES include sustained cyanosis with hypoxia, true lateral tongue biting, stereotyped events that are identical each time, clear postictal confusion or lethargy, and obviously epileptic EEG changes during the events themselves. Now there are some additional historical and contextual clues that can help us make the diagnosis as well. If the events occur in the presence of others, if they occur during stressful situations, if there are psychosocial stressors or trauma history, a lack of response to antiepileptic drugs, or the absence of postictal confusion, this may suggest PNES. Lower socioeconomic status, Medicaid insurance, homelessness, and substance use are also associated with PNES risk. While some of these features increase suspicion, again, video-EEG remains the diagnostic gold standard. We do not have video-EEG in the ED. But during monitoring, typical events are ideally captured and epileptiform activity is not seen on the EEG recording. Video-EEG is not feasible for every single diagnosis. You can make a probable PNES diagnosis with a very accurate clinical history, a vivid description of the signs and appearance of the events, and reassuring interictal EEG findings. Normal labs and normal imaging do not make the diagnosis. Psychiatric comorbidities are not required. The diagnosis, again, rests on positive clinical features. If the patient can't be placed on video-EEG in a monitoring unit, and if they have an EEG in between events and it's normal, that can be supportive as well. So what if you have a patient with PNES in the Emergency Department? Step one, stabilize airway, breathing, circulation. Take care of the patient in front of you and keep them safe. Use seizure pads and precautions and keep them from falling off the bed or accidentally injuring themselves. A family member or another team member can help with this. Avoid reflexively escalating. If you are witnessing a PNES event in front of you, and if they're protecting their airway, oxygenating, and hemodynamically stable, avoid repeated benzodiazepines. Avoid intubating them unless clearly indicated, and avoid reflexively loading them with antiseizure medications such as levetiracetam or valproic acid. Take a focused history. You've gotta find out if they have a prior epilepsy diagnosis. Have they had EEGs before? What triggered today's event? Do they have a psychiatric history? Does the patient have school stressors or family conflict? And then is there any recent illness or injury? Only order labs and imaging when clinically indicated. EEG is not widely available in the Emergency Department. We definitely shouldn't say things like, “this isn't a real seizure,” or use outdated terms like pseudo-seizure. Don't say it's all psychological, and please do not imply that the patient is faking. If you see a patient and you think it's PNES, you're smart, you're probably right, but don't promise diagnostic certainty at first presentation. Remember, a sizable proportion of these patients actually do have epilepsy, and referring them to neurology and getting definitive testing can really help clarify the diagnosis. Communication errors, especially early on, worsen outcomes. One of the most difficult things is actually explaining what's going on to families and caregivers. So here's a suggestion. You could say something like: “What your child is experiencing looks like a seizure, but it's not caused by abnormal electrical activity in the brain. Instead, it's what we call a functional seizure, where the brain temporarily loses control of movement and awareness. These episodes are real and involuntary. The good news is that this condition is treatable, especially when we address it early.” The core treatment of PNES is CBT-based psychotherapy, or cognitive behavioral therapy. That's the standard of care. Typical treatment involves 12 to 14 sessions focused on identifying triggers, modifying maladaptive cognitions, and building coping strategies. Almost two thirds of patients achieve full remission with treatment. About a quarter achieve partial remission. Combined improvement rates reach up to 90 percent at 12 months. Additional issues that neurologists, psychologists, and psychiatrists often face include safe tapering of antiseizure medications when epilepsy has been excluded, treatment of comorbid anxiety or depression, coordinating care between neurology and mental health professionals, and providing education for schools on event management. Schools often witness these events and call prehospital professionals who want to keep patients safe. Benzodiazepines are sometimes given, exposing patients to additional risk. This requires health system-level and outpatient collaboration. Overall, early diagnosis and treatment of PNES is critical. Connection to counseling within one month of diagnosis is the strongest predictor of remission. PNES duration longer than 12 months before treatment significantly reduces the likelihood of remission. Video-EEG confirmation alone does not predict positive outcomes. Not every patient needs admission to a video-EEG unit. Quality of communication and speed of treatment, especially CBT-based therapy, matter the most. Overall, the prognosis for most patients with PNES is actually quite favorable. There are sustained reductions in events along with improvements in mental health comorbidities. Quality of life and psychosocial functioning improve, and patients use healthcare services less frequently. So here are some take-home points about psychogenic non-epileptic seizures, or PNES. Pseudo-seizure and similar terms are outdated and misleading. Do not use them. PNES are real, involuntary, brain-based events. Diagnosis relies on positive clinical features, what the events look like and when they happen, not normal lab tests or CT scans. Early recognition and diagnosis, and rapid referral to cognitive behavioral therapy, change patients' lives. If you suspect PNES, get neurology and mental health professionals involved as soon as possible. Alright, that's all I've got for this episode. I hope you found it educational. Having seen these events many times over the years, I recognize how scary they can be for families, schools, and our prehospital colleagues. It's up to us to think in advance about how we're going to talk to patients and families and develop strategies to help children who are suffering from PNES events. If you've got feedback about this episode, send it my way. Likewise, like, rate, and review, as my teenagers would say, and share this episode with a colleague if you think it would be beneficial. For PEM Currents: The Pediatric Emergency Medicine Podcast, this has been Brad Sobolewski. See you next time.

Send us a textIn this episode of PT Snacks Podcast, host Kasey dives deep into patellar dislocation and the medial patellofemoral ligament (MPFL). Learn about the anatomy, common causes, and risk factors of patellar dislocations, alongside assessment techniques and treatment options. Whether you're a physical therapist or PT student, this episode offers valuable insights into managing both non-operative and post-operative care for patients. Kasey also discusses patient readiness for returning to sports, highlighting the importance of both physiological and psychological factors. Tune in and expand your knowledge on handling one of the most common knee injuries.00:00 Welcome to PT Snacks Podcast00:14 Introduction to MPFL and Patellar Dislocation01:18 Understanding the Medial Patellofemoral Ligament (MPFL)03:02 Risk Factors for Patellar Dislocation05:37 Assessment of Patellar Dislocation07:31 Treatment Approaches for Patellar Dislocation09:01 Rehabilitation and Return to Sport12:15 Summary and Additional Resources13:12 Closing Remarks and AnnouncementsSupport the showNeed CEUs? Unlock unlimited online courses, live webinars, and certification-prep programs with MedBridge. You'll get: Thousands of accredited, evidence-based courses across multiple specialties (PT, OT, AT, SLP) that count for state-license CEUs. Access anytime, from your office, phone, or home—perfect for busy clinicians. One annual subscription, no per-course fee. Special offers: Use code PTSNACKSPODCAST at checkout and save over $100. Students use code PTSNACKSPODCASTSTUDENT for a discounted annual plan. Studying for the NPTE? Check out PT Final Exam — they've helped thousands of students pass with confidence. Use code PTSnacks at checkout for a discount. Stay Connected! Follow so you never miss an episode. Send your questions via email to ptsnackspodcast@gmail.com Join the email list ...

This is one of the most difficult and meaningful conversations Space for Life has ever held.In this episode, host Tommy Thompson is joined by David Dwight, Senior Pastor at Hope Church Richmond, and Ray Paul, National Board Chair of the American Foundation for Suicide Prevention. Together, they share deeply personal stories of losing close family members to suicide and reflect on what it means to grieve, to care for one another, and to hold hope in the midst of profound loss.Listener discretion is advised. This is a heavy and sensitive topic, and we encourage you to listen at your own pace and with support if needed.This conversation is rooted in lived experience, not theory. With honesty, compassion, and care, they explore:What makes suicide-related grief uniquely complexHow to recognize warning signs and risk factorsHow to talk about suicide without shame, fear, or judgmentThe role of community, presence, and faith in healingHow we can better support both those who are grieving and those who may be at riskThis episode is for anyone who has lost someone they love, is walking alongside someone who is struggling, or wants to learn how to respond with greater care and understanding in these moments.Important Support NoteIf you or someone you love is struggling or in crisis, help is available. In the United States, you can call or text 988, the Suicide & Crisis Lifeline, to connect with trained counselors 24/7.You are not alone.Timestamps00:00 Introduction to a Difficult Conversation 03:49 Personal Experiences with Suicide 11:27 Understanding Grief and Loss 24:08 The Complexity of Suicide 32:17 Statistics and Prevention Strategies 42:56 Navigating Conversations about Suicide 54:34 The Role of Community and Support 01:06:17 Faith and Understanding in Grief 01:14:35 Final Thoughts and ResourcesKey Themes & TakeawaysSuicide loss carries layers of grief that are often misunderstoodPrevention and compassion must exist togetherWarning signs often show up as subtle changes in behavior or moodAsking direct questions and listening carefully can save livesPresence matters more than having the “right” wordsThe way someone dies does not define the value or meaning of their lifeHealing often happens in community, not isolationResources MentionedAmerican Foundation for Suicide Prevention (AFSP) https://afsp.orgWhat to Do When Someone Is at Risk https://afsp.org/what-to-do-when-someone-is-at-risk/Risk Factors, Protective Factors, and Warning Signs https://afsp.org/risk-factors-protective-factors-and-warning-signs/Suicide & Crisis Lifeline (U.S.) Call or text 988Love the show? Subscribe, rate, review, and share! http://tommythompson.org

Five articles from the January 2026 issue summarized in five minutes, with the addition of a brief editorial commentary. The 5-in-5 feature is designed to give readers an overview of articles that may pique their interest and encourage more detailed reading. It may also be used by busy readers who would prefer a brief audio summary in order to select the articles they want to read in full. The featured articles this month are: Risk Factors for Progression to Glenohumeral Arthritis After Arthroscopic Anterior Stabilization in a Young and High-Demand Population Characterizing the Transition Zone Between the Meniscotibial Ligament and the Medial Meniscus: A Hidden Trigger for Ramp Lesions Rates of Arthrofibrosis in Adolescent Patients After ACL Reconstruction Using Hamstring Autograft With or Without Lateral Extra-articular Tenodesis Long-term Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome in Master Athletes: A Propensity-Matched Study With Mean 10-Year Follow-up Functional, Radiological, and Scapular Motion Evaluation of Surgical Versus Nonsurgical Treatment of Type 3 Acromioclavicular Dislocations: A Randomized Controlled Trial With 24 months' Follow-up Click here to read the articles.

Dr. Margarita Fedorova outlines how genetic, environmental, and pathological factors interact in Parkinson's disease and what this means for patient counseling.  Show citation:  Blauwendraat C, Morris HR, Van Keuren-Jensen K, Noyce AJ, Singleton AB. The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to prevention. Lancet Neurol. 2025;24(11):969-975. doi:10.1016/S1474-4422(25)00271-6  Show transcript:  Dr. Margarita Federova: Welcome to Neurology Minute. My name is Margarita Fedorova, and I'm a neurology resident at the Cleveland Clinic. Today we're exploring a framework for understanding how genetic, environmental, and pathological factors interact in Parkinson's disease and what this means for how we counsel our patients. A personal view paper by Blauwendraat and colleagues, published in The Lancet Neurology in September 2025, addresses a critical question. We've identified over 100 genetic loci for Parkinson's, but how do they act? The common saying is genetics loads the gun and environment pulls the trigger, but this paper suggests the relationship may be more complex. The key tool here is alpha-synuclein seeding amplification assays or SAAs. These detect misfolded alpha-synuclein protein in cerebrospinal fluid. Over 90% of Parkinson's patients test positive for misfolded alpha-synuclein using this assay. But here's what's notable. 2% to 16% of neurologically healthy older adults also test positive with prevalence increasing with age. This means there are more asymptomatic people with detectable alpha-synuclein pathology than people with actual Parkinson's disease. Most of these asymptomatic individuals will never develop symptoms. This raises an important question. What determines who converts to a disease and who doesn't? By integrating SAA results with genetic data, researchers can examine whether genetic factors drive initial protein misfolding or whether they modulate the response to pathology triggered by environmental or random events. Preliminary data suggests polygenic risk scores don't strongly associate with SAA positivity in healthy older adults. In other words, people with high genetic risk for Parkinson's aren't necessarily more likely to have misfolded alpha-synuclein if they're healthy. This suggests most Parkinson's genetic risk factors may not be causing initial misfolding. Instead, they may be determining what happens afterward, such as whether the pathology progresses to clinical disease. LRRK2 mutations support this model. About 33% of LRRK2 related Parkinson's patients are SAA-negative compared to only 7% in sporadic disease. This means many people with LRRK2 mutations develop Parkinson's without the typical alpha-synuclein pathology. LRRK2 mutations also show varied pathology. Sometimes alpha-synuclein, sometimes tau, sometimes neither. This suggests LRRK2 may modulate responses to different initiating events rather than directly causing protein misfolding. What does this mean for us as clinicians? Asymptomatic SAA-positive individuals could represent a window for intervention. If we can understand what protects them from converting to disease or what triggers that conversion, we could enable earlier identification of at risk individuals and potentially intervene before symptoms develop. The authors call for large scale studies using SAAs in older populations, combined with genetic analysis and longitudinal follow-up. By integrating pathological biomarkers with genetic and environmental data, we can better understand the temporal sequence of events in development of Parkinson's. This approach could fundamentally change how we think about disease prevention and early intervention, potentially allowing us to identify at risk individuals before symptoms appear and develop targeted prevention strategies. That's your neurology minute for today. Keep exploring, and we'll see you next time. If you want to read more, please find the paper by Cornelis Blauwendraat et al titled The Temporal Order of Genetic, Environmental and Pathological Risk Factors in Parkinson's Disease: Paving the Way to Prevention, published online in September 2025 in Lancet Neurology.

Chris Hughen sat down with Franco Impellizzeri to discuss risk factors in sports medicine. We dive into causal versus non-causal mechanisms, challenges in defining risk factors, the importance of transparency in research, the illusion of control in clinic practice, and much more. Watch the full episode: https://youtu.be/_-0yndWOf-w  Episode Resources: Stovitz, 2025 Franco's ResearchGate Franco's X --- Membership: https://e3rehab.com/premium/  Mentoring: https://e3rehab.com/mentoring/ Coaching & Consultations: https://e3rehab.com/coaching/  Rehab & Performance Programs: https://e3rehab.com/programs/  Resource Guides: https://e3rehab.com/resource-guides  Newsletter: https://e3rehab.ck.page/19eae53ac1  --- Follow Us: YouTube: https://www.youtube.com/e3rehab  Instagram: https://www.instagram.com/e3rehab/ X: https://x.com/E3Rehab  LinkedIn: https://www.linkedin.com/company/e3rehab/  Facebook: https://www.facebook.com/e3rehab  --- Podcast Sponsor: Vivo Barefoot: Get 20% off all shoes! - https://www.vivobarefoot.com/e3rehab --- @dr.surdykapt @tony.comella @dr.nicolept @chrishughen @nateh_24 --- This episode was produced by Kody Hughes

In this episode, Dr. Jockers breaks down how common nutrient deficiencies quietly contribute to brain fog, memory loss, and cognitive decline. You will learn why symptoms often blamed on aging may actually be signs of missing key nutrients. The episode sets the foundation for understanding how nutrition directly shapes brain health.   You will learn how deficiencies in magnesium and vitamin D disrupt neurotransmitter balance, increase brain inflammation, and impair mental clarity. Dr. Jockers explains how these imbalances affect mood, focus, and long term cognitive resilience. Subtle warning signs are highlighted that many people overlook.   You will also learn why B12, folate, and vitamin B6 are critical for protecting the brain and nervous system. The episode explores how these nutrients influence oxygen delivery, detoxification, and gene expression. Dr. Jockers shares insights that help connect lab markers with real world cognitive symptoms.   In This Episode:  00:00 Understanding B12 Deficiency in Aging 00:26 Introduction to Nutrient Deficiencies and Brain Health 06:20 The Importance of Magnesium for Brain Function 13:18 Optimizing Vitamin D Levels for Cognitive Health 17:59 The Critical Role of B12 in Brain Health 21:46 B12 Deficiency: A Widespread Issue 24:54 Causes and Risk Factors of B12 Deficiency 28:10 Optimal B12 Levels and Supplementation 32:25 Understanding Folate and Its Importance 38:15 Vitamin B6: Functions and Deficiency Signs 42:56 Conclusion and Final Thoughts   If you want practical, natural strategies to balance your hormones, heal your gut, boost your energy, and slow aging, don't miss The Dr. Josh Axe Show. Dr. Axe blends ancient wisdom with cutting-edge science and brings on world-class experts for unfiltered conversations you won't hear anywhere else. Transform your health from the inside out and subscribe to The Dr. Josh Axe Show, with new episodes every Monday and Thursday.   Support glowing skin, stronger joints, better digestion, and deeper sleep with Paleovalley's 100% Grass-Fed Bone Broth Protein. Unlike most brands that use hides and skins, Paleovalley slow-simmers real beef bones to extract collagen, glycine, and key amino acids that boost metabolism and reduce inflammation. Each scoop delivers 15 grams of collagen and the clinical dose of glycine for better sleep. Get 15% off at paleovalley.com/jockers.   Most tap water contains hidden contaminants that can contribute to fatigue, hormone disruption, and cognitive decline. AquaTru is a countertop water purifier that uses a four stage reverse osmosis system to remove 84 contaminants, including chlorine, lead, PFAS, and microplastics. Unlike standard pitcher filters or bottled water, AquaTru delivers truly purified water with no installation required. It has been featured in Business Insider, Popular Science, and named Best Countertop Water Filter by Good Housekeeping. Save 20% on your AquaTru purifier at aquatru.com using the promo code NUTRITION and try it risk free with a 30 day best tasting water guarantee.     "Magnesium regulates calcium metabolism in neurons. Dysregulated calcium metabolism can lead to neurotoxicity and cause cognitive decline."      Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio   Resources: Paleovalley Bone Broth Protein: Save 15% on grass-fed bone broth protein at paleovalley.com/jockers. Visit aquatru.com and use promo code NUTRITION to save 20% on your AquaTru water purifier.   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

Join Dr. M. Adnan Raufi, an interventional cardiologist, as he uncovers the critical risk factors associated with heart disease in today's episode. Discover the difference between modifiable and non-modifiable risk factors and how lifestyle changes can dramatically reduce your risk of cardiovascular complications.

About Dr. Raj Dr Raj is a quadruple board certified physician and associate professor at the University of Southern California. He was a co-host on the TNT series Chasing the Cure with Ann Curry, a regular on the TV Show The Doctors for the past 7 seasons and has a weekly medical segment on ABC news Los Angeles. More from Dr. Raj ⁠The Dr. Raj Podcast⁠ ⁠Dr. Raj on Twitter⁠ ⁠Dr. Raj on Instagram⁠ Want more board review content? ⁠USMLE Step 1 Ad-Free Bundle⁠ ⁠Crush Step 1⁠ ⁠Step 2 Secrets⁠ ⁠Beyond the Pearls⁠ ⁠The Dr. Raj Podcast⁠ ⁠Beyond the Pearls Premium⁠ ⁠USMLE Step 3 Review⁠ ⁠MedPrepTGo Step 1 Questions⁠ ⁠MedPrepTGo Step 2 Questions⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study supplemented by transcriptome and Mendelian randomization analyses to identify 28 loci and proteins associated with VTE recurrence risk. This work provides genomic evidence that inherited variants contribute to the risk of VTE recurrence, raising the possibility of a more personalized approach to the prevention of recurrent VTE. The study conducted by Dr. Schetelig and colleagues report the results of a long term trial on patients with poor-response AML, comparing outcomes between patients who received salvage chemotherapy versus immediate transplantation. With no difference in survival rates at 5 years, outcomes seem to be determined mainly by genetic risk factors, age, and comorbidities, therefore challenging the routine use of intensive remission induction before allogeneic transplant in patients with an available donor and underscore the need for novel therapeutic strategies for poor-risk AML.Featured Articles:Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial 

Shingles is a reactivation of the varicella‑zoster virus and poses a substantial burden, particularly for older adults and immunocompromised individuals. During this podcast, experts discuss the evolving epidemiology of shingles, distinguish between typical and atypical presentations across dermatologic, neurologic, and ophthalmic domains. Learners will gain insights into prevention strategies including vaccination and timely antiviral therapy to reduce complications. Claim CE and MOC credit at: https://bit.ly/4qkvOPU

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this week's episode of Unlock Your Life, Jennings breaks down the five critical risk factors every real estate investor must know. Drawing from personal experience, Jennings explains why failure is a better teacher than success and how overconfidence can lead to heartbreak. He methodically explores why investing out-of-market, purchasing older buildings, ignoring location fundamentals, venturing into unfamiliar asset classes, and taking on too many deals simultaneously can devastate your portfolio. This episode delivers a masterclass in risk management and emphasizes that operational excellence- not deal acquisition- is the true secret to longevity in real estate investing. Thanks for listening!

Popular media leverage weak study to criticize RFK Jr.'s rethink of standard recommendations for saturated fat avoidance; Poor quality plant-based diets hike cardio risk; A listener complains his lp(a) is going up with age despite his healthy diet, lifestyle; Scientists pinpoint cocoa ingredient that slows aging; Berry proanthocyanidins preserve brain power; Tattooing may promote inflammation, undermine immunity.

In this episode, Dr. Jockers explains why parasite symptoms often intensify around the full moon and how changes in light exposure, serotonin, and melatonin can trigger parasite activity. You'll learn why this timing matters and how it creates a unique window for effective cleansing.   You'll also discover the most common signs of parasite overload—many of which are frequently misattributed to stress, poor digestion, or aging. From sleep disturbances and gut issues to skin reactions and inflammation, this episode connects the dots in ways most people never consider.   Finally, you'll learn the foundational principles behind a successful parasite cleanse, including why drainage, gut motility, and immune support matter just as much as killing parasites. Dr. Jockers walks through the strategy while leaving key insights for you to uncover as you listen.     In This Episode:  00:00 Introduction to Full Moon Parasite Cleanse 00:12 Protocol Overview 02:35 Understanding Parasites and Their Impact 07:21 Risk Factors for Parasite Infections 13:50 Lab Tests and Indicators of Parasites 17:40 Steps for Effective Parasite Cleanse 22:19 Conclusion and Final Thoughts     If you want practical, natural strategies to balance your hormones, heal your gut, boost your energy, and slow aging, don't miss The Dr. Josh Axe Show. Dr. Axe blends ancient wisdom with cutting-edge science and brings on world-class experts for unfiltered conversations you won't hear anywhere else. Transform your health from the inside out and subscribe to The Dr. Josh Axe Show, with new episodes every Monday and Thursday.   Support glowing skin, stronger joints, better digestion, and deeper sleep with Paleovalley's 100% Grass-Fed Bone Broth Protein. Unlike most brands that use hides and skins, Paleovalley slow-simmers real beef bones to extract collagen, glycine, and key amino acids that boost metabolism and reduce inflammation. Each scoop delivers 15 grams of collagen and the clinical dose of glycine for better sleep. Get 15% off at paleovalley.com/jockers.     "By the time you're seeing symptoms like indigestion or skin rashes, parasites may already be wreaking havoc inside your gut."      Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio     Resources: Paleovalley Bone Broth Protein: Save 15% on grass-fed bone broth protein at paleovalley.com/jockers.   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

Send us a message with this link, we would love to hear from you. Standard message rates may apply. In this episode of Your Checkup, we break down lipoprotein(a) — a largely inherited form of cholesterol that can significantly increase the risk of heart disease and stroke, even when standard cholesterol numbers look normal. We talk about what Lp(a) is, why it matters, who should be tested, and how it helps explain “unexpected” heart events in otherwise healthy people. While Lp(a) can't currently be lowered with diet or exercise, knowing your level allows you and your care team to be more intentional about prevention by aggressively managing other risk factors like LDL cholesterol, blood pressure, and diabetes. We also discuss what the numbers mean, why most people only need to be tested once, and the promising treatments currently being studied that may change care in the future. References (for Show Notes)Nordestgaard BG, Langsted A. Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024;404(10459):1255-1264.Reyes-Soffer G, et al. AHA Scientific Statement on Lipoprotein(a). Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60.Di Fusco SA, et al. Lipoprotein(a): Risk Factor and Emerging Target. Heart. 2022;109(1):18-25.Nasrallah N, et al. Lp(a) in Clinical Practice. Eur J Clin Invest. 2025:e70127.Greco A, et al. Lipoprotein(a) as a Pharmacological Target. Circulation. 2025;151(6):400-415.Bess C, Mehta A, Joshi PH. All We Need to Know About Lipoprotein(a). Prog Cardiovasc Dis. 2024;84:27-33.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Are you assuming your partner's fertility is “fine” because his semen analysis came back "normal"—and could that be the very thing blocking pregnancy?!Most couples don't realize that 50% of all fertility challenges involve male factors, yet men rarely receive thorough testing. A basic semen analysis only scratches the surface and completely overlooks hidden issues.In this episode, you'll learn...-A clear understanding of why a standard semen analysis does not confirm healthy or optimal sperm—and what deeper issues it often misses.-The hidden male-factor problems that contribute to infertility, poor embryo development, and miscarriage.-The exact steps couples can take right now—including advanced testing, lifestyle upgrades, and targeted support—to rapidly improve sperm quality in as little as 90 days.Press play now to learn how addressing male fertility today can dramatically boost your chances of conceiving, reduce miscarriage risk, and help you build the healthiest family possible.

An L.A. based podcast brought to you by two forensic psychologists who dissect the intersections where true crime, forensic psychology, and entertainment meet. Episode Description: Crazy In Love: Erotomania Dr. Scott & Dr. Shiloh get into the subcategory of Delusional Disorder, Erotomania; to have the delusional or false belief of a secret or known admirer. This disorder is often the trigger for obsessive celebrity stalkers and has been the cause for numerous violent acts. The docs explore the origin, criteria, and research of this rare phenomenon and cover the cases of John Hinkley Jr., Margaret Mary Ray, and the shooter who killed rising star Christina Grimmie. Related episode: Stalking: The Crime of the 90's https://anchor.fm/lansc/episodes/25--Stalking-The-Crime-of-the-90s-e537ff Donate to the Christina Grimmie Foundation here: https://christinagrimmiefoundation.org/ Mentions: Lenora Consulting LLC https://www.lenoraclairellc.com/ 10ish Podcast https://www.10ishpod.com/ Resources Braun, Claude, and Sabrina Suffren. "A General Neuropsychological Model of Delusion." ResearchGate, Taylor & Francis (Routledge), Mar. 2010, www.researchgate.net/publication/41670340_A_general_neuropsychological_model_of_delusion. Accessed 26 Nov. 2021. Brüne, Martin. "Erotomanic Stalking in Evolutionary Perspective." Behavioral Sciences & the Law, vol. 21, no. 1, 16 Dec. 2002, pp. 83–88, pubmed.ncbi.nlm.nih.gov/12579619/#:~:text=Erotomania%2C%20the%20delusion%20of%20being,concerning%20prevalence%20rates%20and%20behavior.&text=The%20evolutionary%20perspective%20may%20provide,understanding%20of%20forensically%20relevant%20behaviors., 10.1002/bsl.518. Accessed 26 Nov. 2021. Christina Grimmie: The Murder of a Rising Star. Orlando Sentinel, 4 June 2018, disc 1-2. Podcast. "De Clerambault Syndrome (Erotomania) in the Criminal Justice System: Another Look at This Recurring Problem | Office of Justice Programs." Ojp.gov, 2021, www.ojp.gov/ncjrs/virtual-library/abstracts/de-clerambault-syndrome-erotomania-criminal-justice-system-another. Accessed 26 Nov. 2021. Ghosh, Tulika, and Minkesh Chowdhary. De Clerambault Syndrome: Current Perspective. Www.intechopen.com, IntechOpen, 12 May 2021, www.intechopen.com/chapters/72361. Accessed 27 Nov. 2021. Hayes, Crystal. "Forgotten Story of Singer's Legacy, Man Who Killed Her." Courier-Post, 18 Dec. 2016, www.courierpostonline.com/story/news/local/south-jersey/2016/12/18/forgotten-story-christina-grimmie-and-man-who-killed-her/95585040/. He Loves Me, He Loves Me Not. Directed by Laetitia Colombani, Samuel Goldwyn Films, 2003. Harmon RB;Rosner R;Owens H. "Obsessional Harassment and Erotomania in a Criminal Court Population." Journal of Forensic Sciences, vol. 40, no. 2, 2011, pubmed.ncbi.nlm.nih.gov/7602275/. Accessed 26 Nov. 2021. "How History Changed Anita Hill (Published 2019)." The New York Times, 2021, www.nytimes.com/2019/06/17/us/anita-hill-women-power.html. Accessed 27 Nov. 2021. Jamaluddin, Ruzita. "Same Gender Erotomania: When the Psychiatrist Became the Delusional Theme—a Case Report and Literature Review." Case Reports in Psychiatry, vol. 2021, 1 Sept. 2021, p. e7463272, www.hindawi.com/journals/crips/2021/7463272/, 10.1155/2021/7463272. Kelly, B. D., et al. "Delusion and Desire: Erotomania Revisited." Acta Psychiatrica Scandinavica, vol. 102, no. 1, July 2000, pp. 74–76, pubmed.ncbi.nlm.nih.gov/10892614/, 10.1034/j.1600-0447.2000.102001074.x. Accessed 26 Nov. 2021. Meloy, J. CASE REPORT Erotomania, Triangulation, and Homicide. "Risk Factors for Stalking Violence, Persistence, and Recurrence." The Journal of Forensic Psychiatry & Psychology, 2017, www.tandfonline.com/doi/abs/10.1080/14789949.2016.1247188?journalCode=rjfp20&. Accessed 26 Nov. 2021. Safeekh, AT, and Denzil Pinto. "Venlafaxine-Induced Psychotic Symptoms." Indian Journal of Psychiatry, vol. 51, no. 4, 2009, p. 308, www.ncbi.nlm.nih.gov/pmc/articles/PMC2802382/, 10.4103/0019-5545.58301. Accessed 26 Nov. 2021. Sederholm, Jillian. "Gunman Who Killed 'the Voice' Singer Had Extra Ammo, Knife: Police." NBC News, 11 June 2016, www.nbcnews.com/news/us-news/voice-singer-christina-grimmie-shot-after-florida-concert-n590161. Accessed 27 Nov. 2021. Shanee Edwards. "I Just Discovered the Crazy World of Erotomania Thanks to HBO's Confirmation." SheKnows, SheKnows, 17 Apr. 2016, www.sheknows.com/entertainment/articles/1119045/erotomania-and-confirmation-hbo/. Accessed 26 Nov. 2021.

Todd Love, Psy.D., JD, explores the science linking ADHD and behavioral addictions — from gambling and pornography to gaming and social media. He explains the toll these behaviors take on daily life and highlights strategies that promote recovery. Behavioral Addictions and ADHD: Resources Free Download: Your ADHD Dopamine Menu Template Read: ADHD and Addiction: The Truth About Substance Abuse Read: Video Game Addiction: Signs, Risk Factors, and ADHD Links Read: Never Enough? Why ADHD Brains Crave Stimulation Access the video and slides for podcast episode #583 here: https://www.additudemag.com/webinar/behavioral-addiction-adhd/ Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.

The McCullough Report with Dr. Peter McCullough – A comprehensive new report from the McCullough Foundation reveals strong evidence linking early childhood vaccination to increased autism risk. Drawing on over a hundred studies, researchers challenge long-held assumptions about vaccine safety and call for urgent public health reforms, including suspension of vaccine mandates and a reexamination of the National Childhood...